About
Generics, Traditional Medicines, APIs
Areas of Focus
Categories
API FocusedSmall Molecule PharmaceuticalChina
Clinical Trials (28)
View allTotal Trials
28
As Lead Sponsor
27
As Collaborator
1
Total Enrollment
38,907
By Phase
PHASE2: 7PHASE3: 8EARLY_PHASE1: 2NA: 3PHASE1: 3PHASE4: 4PHASE2/PHASE3: 1
By Status
COMPLETED: 14UNKNOWN: 11RECRUITING: 3
Clinical Trials Pipeline28 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06963320Lead Sponsor
Phase II Clinical Study of H001 Capsule in the Prevention of Venous Thromboembolism After Total Knee Arthroplasty
PHASE2Recruiting
320 participants
Started: Jan 20, 2025 · Completed: Jul 30, 2025
NCT06850480Lead Sponsor
A Phase III Clinical Trial for Efficacy and Safety Evaluation of JP-1366 Tablets on Reflux Esophagitis
PHASE3Recruiting
356 participants
Started: Dec 5, 2024 · Completed: Apr 30, 2025
NCT06110676Lead Sponsor
A Study to Evaluate the Efficacy and Safety of LZM012
PHASE3Recruiting
918 participants
Started: Aug 21, 2023 · Completed: Jun 30, 2025
NCT05585567Lead Sponsor
A Preliminary Exploratory Study to Evaluate the Safety and Immunogenicity of Omicron Variant Bivalent Vaccine V-01-B5
EARLY_PHASE1Unknown
48 participants
Started: Sep 16, 2022 · Completed: Sep 11, 2023
NCT05583357Lead Sponsor
Exploratory Clinical Study to Evaluation of the Safety and Immunogenicity of Bivalent Vaccine V-01D-351
EARLY_PHASE1Unknown
40 participants
Started: Aug 15, 2022 · Completed: Aug 10, 2023
Locations (1)
Headquarters
Zhuhai, China
Map
Loading map...